Can a Genomic Test Better Detect Aggressive Prostate Cancer?

Can a Genomic Test Better Detect Aggressive Prostate Cancer? - NCI

Research on prostate cancer suggests the Decipher genomic test finds aggressive prostate cancer better than other methods, especially in ...

Biomarkers & Genomic Testing - ZERO Prostate Cancer

A family history increases a man's risk for prostate cancer by up to 60%. View the table below for more information, and keep scrolling for more on biomarker ...

Genetic and Genomic Testing for Prostate Cancer: Beyond DNA ...

Minimally invasive circulating tumor DNA (ctDNA) tests are used to identify treatment-predictive and prognostic biomarkers in advanced prostate ...

National Cancer Institute (NCI) on LinkedIn: Can a Genomic Test ...

A genomic test has found high-risk prostate cancer even when conventional tests said the tumors were lower risk.

Genomic Test Helps Estimate Risk of Prostate Cancer Metastasis ...

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy.

Test May Show Whether to Treat Prostate Cancer with Hormones - NCI

For some men with prostate cancer, a genetic biomarker test called Decipher may help predict whether the cancer will spread to other parts ...

The Role of Genomic Testing in Prostate Cancer - Patient Power

A genomic test called Decipher can predict how likely a tumor is to metastasize within the next five years. It might also be better at ...

Prostate Cancer and Genetic Testing - WebMD

Genetic mutations passed down through families cause up to 12% of prostate cancers. Genetic testing could provide information that changes ...

Patient experiences with tissue‐based genomic testing during active ...

Tissue‐based gene expression (genomic) tests provide estimates of prostate cancer aggressiveness and are increasingly used for patients ...

Genetic Testing for Prostate Cancer: What You Should Know

BRCA2, in particular, is linked to aggressive prostate cancer. Other genes that can cause prostate cancer through mutations involve HOXB13, ATM and genes known ...

Guidelines for genetic testing in prostate cancer: a scoping review

Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men ...

Genetic Testing | ZERO Prostate Cancer

Genetic testing identifies gene mutations that can impact patients and their families. These tests are used by doctors to learn more about a patient's ...

Genomic Testing Can ID High-Risk African American Prostate ...

However, these examinations and tests are not optimal to identify aggressive disease because they rely on features of the tumor cells and ...

Toward Informed Selection and Interpretation of Clinical Genomic ...

In prostate cancer (PCa), broad genotyping tests are now widely used to identify germline and/or somatic alterations in BRCA2 and other DNA ...

Prostate cancer genomic testing is flawed: Three reasons why

Men with prostate cancer want to know the future: Will my cancer get worse? Do I need surgery? Genomic testing can help us make educated ...

Genomic Testing & Biomarkers | PCFA

Biomarker testing can help with prostate cancer detection and diagnosis and can guide your doctor in deciding the best treatment options for you. This is ...

Genetic Testing for Prostate Cancer

We now know that some of the same gene mutations that cause prostate cancer can also cause other forms of cancer (such as breast, colon, pancreatic, and others) ...

Prostate cancer - Diagnosis and treatment - Mayo Clinic

Genomic testing analyzes your prostate cancer cells ... Your doctor will help determine which tests are best for your individual situation.

ASCO 2024: Prostate cancer spit test better for men with high ...

Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in practice – we can ...

The Decipher Biopsy test could help predict aggressive prostate ...

... commercially available genomic test known as Decipher Biopsy may help identify patients who are at high risk of prostate cancer progression.